Author: Avalon Health Economics LLC

Environmental Health Update: Ending our Love Affair with Styrofoam
September 5, 2014 - 1:53 pm, by , in Blog
For over 50 years, the food industry has used Expanded Polystyrene (EPS) food service products for a variety of food and beverage service needs. EPS, commonly known as Styrofoam, is cheap and durable, so it seems ideal for takeout food or your hot cup of to-go coffee. But you might want to rethink drinking your...
Ivana Stojanovic, MA, has joined Avalon Health Economics as a Health Economist
September 5, 2014 - 11:23 am, by , in News
Ivana Stojanovic, MA, has joined Avalon Health Economics as a Health Economist. Ivana has several years of experience in economics consulting, and has expertise in conducting data analysis and research for litigation support. Her quantitative skills include SAS, SQL, STATA, and Basic VBA. Click here for Ivana’s full biosketch.
What are the Health Consequences of Psychiatric Hospital Closures?
August 25, 2014 - 1:51 pm, by , in Blog
Over the past 50 years, 95% of the country’s state psychiatric hospital population have been closed down, leaving fewer than 200 hospitals to provide care to those living with mental illnesses (Fisher et al. 2009). Between 2009 and 2011 alone, states cumulatively cut more than $1.8 billion from their budgets for services for children and...
The Costs of Antibiotic Resistance and the Need for Antibiotic Stewardship
August 18, 2014 - 1:45 pm, by , in Blog
After suffering from a nasty cold for more than a few days, many of us think about checking in with our doctor just to be sure that it’s not something worse. The result on those visits is, all too often, a simple confirmation of what you already knew: you have a cold. You’ll get better....
Return-on-Investment of Workplace Health Promotion Programs
August 18, 2014 - 1:40 pm, by , in Blog
Recent healthcare reforms in the U.S. and abroad have emphasized the value of meaningful and effective preventative care and health promotion. Corporations are taking note, and, as a result, there has been a significant rise in the number of corporate wellness programs popping up. Under recent healthcare legislation in the U.S., there are tax incentives...
Avalon Health Economics will be attending Nordic Life Science Days 2014, Stockholm, Sweden, September 7-9
July 18, 2014 - 11:21 am, by , in News
Avalon Health Economics will be attending Nordic Life Science Days 2014, Stockholm, Sweden, September 7-9. Avalon will present “Establishing the Value of New Drugs, Devices & Diagnostics” (See Presentation). The NLSD is the largest life sciences meeting held in the Nordic region, and will include representatives from pharmaceutical companies, medical device makers, diagnostics companies, and...
E-Cigarettes and Tobacco Policy
July 7, 2014 - 1:37 pm, by , in Blog
1. What is an E-Cig? The “e-cig” is an electronic cigarette that is used to simulate the experience of smoking that has a cartridge with a heater that vaporizes liquid nicotine instead of burning tobacco. Having become a seemingly overnight sensation, governments in both Europe and the United States are struggling with how to regulate...
Noemi Kiss and Azal Ahmadi join Avalon Health Economics
July 7, 2014 - 11:19 am, by , in News
Noemi Kiss is a Senior Health Economist with Avalon. She recently earned her MSc in Health Economics from the University of York (United Kingdom). Prior to York, Ms. Kiss was a Health Economist at Oxford Outcomes, Ltd (and Oxford’s parent company ICON plc), from 2010-13. Click here to read her biosketch. In addition to her...
James Robinson joins Avalon Health Economics as a Director
July 7, 2014 - 11:17 am, by , in News
James Robinson joins Avalon Health Economics as a Director. Jamie is the Leonard D. Schaeffer Professor of Health Economics and Director of the Berkeley Center for Health Technology (BCHT) at the University of California at Berkeley. In addition to his role as Director at Avalon Health Economics, his professional activities include his roles as Senior...
Watch Avalon’s presentation at EuroMedtech in Linz, Austria in May 2014 entitled “Establishing the Value of New Drugs, Devices, & Diagnostics”
July 7, 2014 - 11:15 am, by , in News
Click here to view the presentation